Laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed/refractory multiple myeloma
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-07-01
|
| Series: | eJHaem |
| Online Access: | https://doi.org/10.1002/jha2.34 |
| _version_ | 1797739964750888960 |
|---|---|
| author | Louisa Shackleton James Fay Elizabeth Smyth Philip Murphy Siobhan Glavey John Quinn |
| author_facet | Louisa Shackleton James Fay Elizabeth Smyth Philip Murphy Siobhan Glavey John Quinn |
| author_sort | Louisa Shackleton |
| collection | DOAJ |
| first_indexed | 2024-03-12T14:05:45Z |
| format | Article |
| id | doaj.art-705a3e0b78604ec8932b1b0642e2e797 |
| institution | Directory Open Access Journal |
| issn | 2688-6146 |
| language | English |
| last_indexed | 2024-03-12T14:05:45Z |
| publishDate | 2020-07-01 |
| publisher | Wiley |
| record_format | Article |
| series | eJHaem |
| spelling | doaj.art-705a3e0b78604ec8932b1b0642e2e7972023-08-21T14:10:49ZengWileyeJHaem2688-61462020-07-011131231410.1002/jha2.34Laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed/refractory multiple myelomaLouisa Shackleton0James Fay1Elizabeth Smyth2Philip Murphy3Siobhan Glavey4John Quinn5Department of Haematology Beaumont Hospital Dublin IrelandDepartment of Haematology Beaumont Hospital Dublin IrelandDepartment of Haematology Beaumont Hospital Dublin IrelandDepartment of Haematology Beaumont Hospital Dublin IrelandDepartment of Haematology Beaumont Hospital Dublin IrelandDepartment of Haematology Beaumont Hospital Dublin Irelandhttps://doi.org/10.1002/jha2.34 |
| spellingShingle | Louisa Shackleton James Fay Elizabeth Smyth Philip Murphy Siobhan Glavey John Quinn Laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed/refractory multiple myeloma eJHaem |
| title | Laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed/refractory multiple myeloma |
| title_full | Laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed/refractory multiple myeloma |
| title_fullStr | Laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed/refractory multiple myeloma |
| title_full_unstemmed | Laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed/refractory multiple myeloma |
| title_short | Laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed/refractory multiple myeloma |
| title_sort | laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed refractory multiple myeloma |
| url | https://doi.org/10.1002/jha2.34 |
| work_keys_str_mv | AT louisashackleton laboratoryfeaturesoftumourlysissyndromefollowingdaratumumabmonotherapyinrelapsedrefractorymultiplemyeloma AT jamesfay laboratoryfeaturesoftumourlysissyndromefollowingdaratumumabmonotherapyinrelapsedrefractorymultiplemyeloma AT elizabethsmyth laboratoryfeaturesoftumourlysissyndromefollowingdaratumumabmonotherapyinrelapsedrefractorymultiplemyeloma AT philipmurphy laboratoryfeaturesoftumourlysissyndromefollowingdaratumumabmonotherapyinrelapsedrefractorymultiplemyeloma AT siobhanglavey laboratoryfeaturesoftumourlysissyndromefollowingdaratumumabmonotherapyinrelapsedrefractorymultiplemyeloma AT johnquinn laboratoryfeaturesoftumourlysissyndromefollowingdaratumumabmonotherapyinrelapsedrefractorymultiplemyeloma |